Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

XORTX Therapeutics Inc (OTCQB: XRTXD)

 
XRTXD Technical Analysis
5
As on 14th Dec 2021 XRTXD STOCK Price closed @ 1.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.41 & Strong Sell for SHORT-TERM with Stoploss of 1.74 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

XRTXDSTOCK Price

Open 2.13 Change Price %
High 2.14 1 Day -0.17 -8.21
Low 1.85 1 Week -0.09 -4.52
Close 1.90 1 Month -0.76 -28.57
Volume 40211 1 Year -0.77 -28.84
52 Week High 4.00 | 52 Week Low 1.89
 
OTCQB USA Most Active Stocks
BMIX 0.01 %
MOBQ 0.18 -5.26%
FNMA 0.45 0.00%
ALPP 3.56 -0.80%
ALPP 3.56 -0.80%
SHMP 0.06 0.00%
NWBO 0.73 0.00%
VPLM 0.08 %
NLST 3.72 -8.60%
SRNA 2.78 14.88%
 
OTCQB USA Top Gainers Stocks
EMMLF 0.89 8800.00%
EWLUD 0.45 275.00%
RASP 0.03 200.00%
RASP 0.03 200.00%
SSEBF 0.02 100.00%
NVAAF 0.40 100.00%
PWWBF 0.02 100.00%
HCAND 0.02 100.00%
SIXWF 0.02 100.00%
IPCIF 0.06 100.00%
 
OTCQB USA Top Losers Stocks
LKMNF 0.01 -50.00%
ALDS 0.01 -50.00%
GMGT 0.03 -50.00%
BNKL 0.60 -39.39%
PPCB 0.05 -37.50%
ATAO 0.09 -35.71%
FCIC 0.38 -34.48%
PKTX 0.02 -33.33%
MNTR 0.02 -33.33%
MNTR 0.02 -33.33%
 
 
XRTXD
Daily Charts		 XRTXD
Intraday Charts		 Whats New @
Bazaartrend		 XRTXD
Free Analysis
 
XRTXD Important Levels Intraday
RESISTANCE2.46
RESISTANCE2.28
RESISTANCE2.17
RESISTANCE2.06
SUPPORT1.74
SUPPORT1.63
SUPPORT1.52
SUPPORT1.34
 
XRTXD Forecast May 2024
Share
4th UP Forecast9.82
3rd UP Forecast7.28
2nd UP Forecast5.71
1st UP Forecast4.14
1st DOWN Forecast-0.34
2nd DOWN Forecast-1.91
3rd DOWN Forecast-3.48
4th DOWN Forecast-6.02
 
XRTXD Weekly Forecast
4th UP Forecast8.28
3rd UP Forecast6.23
2nd UP Forecast4.97
1st UP Forecast3.70
1st DOWN Forecast0.10
2nd DOWN Forecast-1.17
3rd DOWN Forecast-2.43
4th DOWN Forecast-4.48
 
XRTXD Forecast2024
4th UP Forecast9.82
3rd UP Forecast7.28
2nd UP Forecast5.71
1st UP Forecast4.14
1st DOWN Forecast-0.34
2nd DOWN Forecast-1.91
3rd DOWN Forecast-3.48
4th DOWN Forecast-6.02
 
 
XRTXD Other Details
Segment EQ
Market Capital 44705820.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
XRTXD Address
XRTXD
 
XRTXD Latest News
 
Your Comments and Response on XORTX Therapeutics Inc
 
XRTXD Business Profile
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is headquartered in Vancouver, Canada. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service